Footer - Free News - PharmProm.Net - Pharmaceutical Industry Information Portal

Type here...

News
Insights
Innovation
Events
Companies
Glossary

Instagram

Twitter

About us
GMP Database
Services
Promotion
Contact
🌐 RU

Pharmaceutical Industry News & Insights

About us
GMP Database
Services
Promotion
Contact
🌐 RU

type here...

Flipboard

Tumblr

News
- All EAEU Market Education Global Markets Manufacturing
  
  Approvals
  Japan Becomes First in the World to Approve iPS Cell-Based Therapy for Parkinson’s Disease
  
  News
  IQVIA Enters the Early-Stage Drug Development Market by Acquiring Charles River Laboratories Assets
  
  News
  Pharmaceutical Logistics Operator Santens Group Transfers to Russian Jurisdiction
  
  News
  EBRD to Finance the Expansion of Pharmaceutical Production in Uzbekistan with €20 Million
Insights
- All Expert Opinion Partner Posts
  
  Expert Opinion
  GMP Registry Update: 8 New Certificates by the End of February 2026
  
  Expert Opinion
  Vadim Kukava: The Pharmaceutical Industry Should Not Be Divided into “Theirs” and “Ours”
  
  Global Markets
  Top Ten Most Anticipated Drug Launches of 2026 That Will Reshape the Global Market
  
  Expert Opinion
  The Paradox of Russian Pharma: About 700 Pharmaceutical Companies Operate in Russia Without GMP Certificates
Innovation
- All AI in Pharma Approvals Drug Development Research
  
  Approvals
  Japan Becomes First in the World to Approve iPS Cell-Based Therapy for Parkinson’s Disease
  
  Drug Development
  A Line of Eight Probiotic-Based Edible Vaccines Developed in Russia
  
  AI in Pharma
  Eli Lilly and Nvidia Launch LillyPod — The Most Powerful AI Supercomputer in Global Pharma
  
  News
  Sechenov University Unveils World’s First Effective CRISPR Delivery System
Events
- All Reports Upcoming
  
  Upcoming
  PHARMPROM Portal Becomes a Media Partner of the International Pharmacovigilance World 2026 Conference
  
  Reports
  Session “EAEU’s common market of medicinal products for veterinary use” at the All-Russian GMP Conference 2025
  
  Reports
  Moscow Hosts the X GMP Conference Under the Motto “Regulating Today — Creating a Stable Tomorrow”
  
  Reports
  Pharmtech & Ingredients International Exposition 2022 Results
Companies
Glossary

Hot topics

Manufacturing
Regulatory
AI in Pharma
Expert Opinion
Global Markets

Instagram

Twitter

Manufacturing

Production of the Russian Smallpox Drug “NIOCH-14” May Start in the Spring of 2026

This is the first chemical drug in Russia intended for the treatment and emergency prevention of smallpox and other orthopoxvirus infections, including mpox.

R-Pharm Import-Substitutes German Erbitux — Drug for Head and Neck Cancer Therapy

The Ministry of Health of the Russian Federation has...

Petrovax Pharm Investments in Meningitis Vaccine Production Exceed 3 Billion Rubles

Biopharmaceutical company Petrovax Pharm has announced receiving an expanded...

00:00:22

Ellara Prepares to Launch Unique Peptide Synthesis Facility

Pharmaceutical company Ellara is completing preparations for the opening...

GMP Registry: New Certificates Issued and Refusals in January 2026

On January 26, the Ministry of Industry and Trade...

Global Markets

EU Approves the Most Extensive Pharmaceutical Legislation Reform in 20 Years

The European Parliament and the Council of the European...

Eli Lilly and Nvidia Launch LillyPod — The Most Powerful AI Supercomputer in Global Pharma

On February 25, 2026, pharmaceutical giant Eli Lilly officially...

EMA is Looking for a New Director. The Most Prestigious Vacancy in European Pharmaceuticals Has Opened

On February 20, 2026, the race for one of...

Top Ten Most Anticipated Drug Launches of 2026 That Will Reshape the Global Market

Experts from Evaluate forecast a record year for the...

An “AI Pill” for Indian Pharma: Sun Pharma and Glenmark Change the Rules of the Game

The Indian pharmaceutical industry, long known as the "pharmacy of the world" due to its generic drug production, is beginning a technological transformation.

Politics

Rospotrebnadzor Cleans Up the Web: 3,000 Resources with Dangerous Dietary Supplements Blocked

The Federal Service for Surveillance on Consumer Rights Protection...

Automated Fines for Expired Dietary Supplements to Start March 1 for Pharmacies

The dietary supplement (BAA) market will be the first...

EMA and PIC/S Tighten Control Over Active Pharmaceutical Substance Production

The European Medicines Agency (EMA), in collaboration with the...

What Happens in 2031? Regulator Sets “Deadline” for EAEU Veterinary Drug Rules

Since March 2024, supranational rules for the circulation of...

Transition to EAEU Standards: GMP Certification Rules for Veterinary Drugs are Changing

A draft Decree of the Government of the Russian...

AI in Pharma

Eli Lilly and Nvidia Launch LillyPod — The Most Powerful AI Supercomputer in Global Pharma

On February 25, 2026, pharmaceutical giant Eli Lilly officially...

An “AI Pill” for Indian Pharma: Sun Pharma and Glenmark Change the Rules of the Game

The Indian pharmaceutical industry, long known as the "pharmacy of the world" due to its generic drug production, is beginning a technological transformation.

SUSU Scientists Synthesize a Selective Anti-Anxiety Molecule

Researchers at South Ural State University (SUSU) have discovered...

Neural Network Breakthrough: FDA Approves Trials for AI-Created Parkinson’s Drug

January 23, 2026, became a landmark date for digital...

Good AI Practice: EMA and FDA Establish 10 Global Principles

Global regulators are setting a unified standard for the...

News
- All EAEU Market Education Global Markets Manufacturing
  
  Approvals
  Japan Becomes First in the World to Approve iPS Cell-Based Therapy for Parkinson’s Disease
  
  News
  IQVIA Enters the Early-Stage Drug Development Market by Acquiring Charles River Laboratories Assets
  
  News
  Pharmaceutical Logistics Operator Santens Group Transfers to Russian Jurisdiction
  
  News
  EBRD to Finance the Expansion of Pharmaceutical Production in Uzbekistan with €20 Million
Insights
- All Expert Opinion Partner Posts
  
  Expert Opinion
  GMP Registry Update: 8 New Certificates by the End of February 2026
  
  Expert Opinion
  Vadim Kukava: The Pharmaceutical Industry Should Not Be Divided into “Theirs” and “Ours”
  
  Global Markets
  Top Ten Most Anticipated Drug Launches of 2026 That Will Reshape the Global Market
  
  Expert Opinion
  The Paradox of Russian Pharma: About 700 Pharmaceutical Companies Operate in Russia Without GMP Certificates
Innovation
- All AI in Pharma Approvals Drug Development Research
  
  Approvals
  Japan Becomes First in the World to Approve iPS Cell-Based Therapy for Parkinson’s Disease
  
  Drug Development
  A Line of Eight Probiotic-Based Edible Vaccines Developed in Russia
  
  AI in Pharma
  Eli Lilly and Nvidia Launch LillyPod — The Most Powerful AI Supercomputer in Global Pharma
  
  News
  Sechenov University Unveils World’s First Effective CRISPR Delivery System
Events
- All Reports Upcoming
  
  Upcoming
  PHARMPROM Portal Becomes a Media Partner of the International Pharmacovigilance World 2026 Conference
  
  Reports
  Session “EAEU’s common market of medicinal products for veterinary use” at the All-Russian GMP Conference 2025
  
  Reports
  Moscow Hosts the X GMP Conference Under the Motto “Regulating Today — Creating a Stable Tomorrow”
  
  Reports
  Pharmtech & Ingredients International Exposition 2022 Results
Companies
Glossary

Hot topics

Manufacturing
Regulatory
AI in Pharma
Expert Opinion
Global Markets

Instagram

Twitter

Manufacturing

Production of the Russian Smallpox Drug “NIOCH-14” May Start in the Spring of 2026

This is the first chemical drug in Russia intended for the treatment and emergency prevention of smallpox and other orthopoxvirus infections, including mpox.

R-Pharm Import-Substitutes German Erbitux — Drug for Head and Neck Cancer Therapy

The Ministry of Health of the Russian Federation has...

Petrovax Pharm Investments in Meningitis Vaccine Production Exceed 3 Billion Rubles

Biopharmaceutical company Petrovax Pharm has announced receiving an expanded...

00:00:22

Ellara Prepares to Launch Unique Peptide Synthesis Facility

Pharmaceutical company Ellara is completing preparations for the opening...

GMP Registry: New Certificates Issued and Refusals in January 2026

On January 26, the Ministry of Industry and Trade...

Global Markets

EU Approves the Most Extensive Pharmaceutical Legislation Reform in 20 Years

The European Parliament and the Council of the European...

Eli Lilly and Nvidia Launch LillyPod — The Most Powerful AI Supercomputer in Global Pharma

On February 25, 2026, pharmaceutical giant Eli Lilly officially...

EMA is Looking for a New Director. The Most Prestigious Vacancy in European Pharmaceuticals Has Opened

On February 20, 2026, the race for one of...

Top Ten Most Anticipated Drug Launches of 2026 That Will Reshape the Global Market

Experts from Evaluate forecast a record year for the...

An “AI Pill” for Indian Pharma: Sun Pharma and Glenmark Change the Rules of the Game

The Indian pharmaceutical industry, long known as the "pharmacy of the world" due to its generic drug production, is beginning a technological transformation.

Politics

Rospotrebnadzor Cleans Up the Web: 3,000 Resources with Dangerous Dietary Supplements Blocked

The Federal Service for Surveillance on Consumer Rights Protection...

Automated Fines for Expired Dietary Supplements to Start March 1 for Pharmacies

The dietary supplement (BAA) market will be the first...

EMA and PIC/S Tighten Control Over Active Pharmaceutical Substance Production

The European Medicines Agency (EMA), in collaboration with the...

What Happens in 2031? Regulator Sets “Deadline” for EAEU Veterinary Drug Rules

Since March 2024, supranational rules for the circulation of...

Transition to EAEU Standards: GMP Certification Rules for Veterinary Drugs are Changing

A draft Decree of the Government of the Russian...

AI in Pharma

Eli Lilly and Nvidia Launch LillyPod — The Most Powerful AI Supercomputer in Global Pharma

On February 25, 2026, pharmaceutical giant Eli Lilly officially...

An “AI Pill” for Indian Pharma: Sun Pharma and Glenmark Change the Rules of the Game

The Indian pharmaceutical industry, long known as the "pharmacy of the world" due to its generic drug production, is beginning a technological transformation.

SUSU Scientists Synthesize a Selective Anti-Anxiety Molecule

Researchers at South Ural State University (SUSU) have discovered...

Neural Network Breakthrough: FDA Approves Trials for AI-Created Parkinson’s Drug

January 23, 2026, became a landmark date for digital...

Good AI Practice: EMA and FDA Establish 10 Global Principles

Global regulators are setting a unified standard for the...

About us
GMP Database
Services
Promotion
Contact
🌐 RU

PHARMPROM is a premier digital resource for the pharmaceutical sector, combining breaking news, deep insights, and key market events. We cover the entire product lifecycle—from R&D and manufacturing to distribution—in strict accordance with Good Pharmaceutical Practices (GxP).

Disclaimer All content on pharmprom.net is for informational purposes only and does not constitute medical advice. The materials are intended exclusively for industry professionals and are not addressed to the general public.

Company

News
Insights
Innovation
Events
Companies
Glossary

I've read and accept the Privacy Policy.

Flipboard

Tumblr

About us
GMP Database
Services
Promotion
Contact
🌐 RU

Company

News
Insights
Innovation
Events
Companies
Glossary

I've read and accept the Privacy Policy.

Flipboard

Tumblr

Hot topics

Manufacturing

Global Markets

Politics

AI in Pharma

Hot topics

Manufacturing

Global Markets

Politics

AI in Pharma

Company

Headlines

Newsletter

Company

Headlines

Newsletter